Stephens Investment Management Group LLC Raises Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Stephens Investment Management Group LLC increased its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 1.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,069,446 shares of the company's stock after acquiring an additional 19,009 shares during the period. HealthEquity comprises about 1.4% of Stephens Investment Management Group LLC's investment portfolio, making the stock its 17th biggest holding. Stephens Investment Management Group LLC owned 1.24% of HealthEquity worth $94,507,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC lifted its position in HealthEquity by 24.7% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company's stock valued at $564,000 after purchasing an additional 1,265 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in HealthEquity by 7,983.6% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company's stock valued at $2,179,000 after purchasing an additional 24,350 shares in the last quarter. GAMMA Investing LLC lifted its position in HealthEquity by 25.9% during the first quarter. GAMMA Investing LLC now owns 1,571 shares of the company's stock valued at $139,000 after purchasing an additional 323 shares in the last quarter. Pier Capital LLC purchased a new position in HealthEquity during the fourth quarter valued at $8,024,000. Finally, HighTower Advisors LLC lifted its position in HealthEquity by 4.8% during the fourth quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock valued at $9,122,000 after purchasing an additional 4,370 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity Price Performance

Shares of NASDAQ:HQY traded up $1.49 during mid-day trading on Wednesday, reaching $97.67. The stock had a trading volume of 940,815 shares, compared to its average volume of 871,267. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The company has a market cap of $8.45 billion, a P/E ratio of 71.29, a price-to-earnings-growth ratio of 1.49 and a beta of 0.49. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $116.65. The business's 50 day moving average price is $101.33 and its 200 day moving average price is $98.42.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The company had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. During the same period in the previous year, the firm posted $0.80 earnings per share. Research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the sale, the executive vice president directly owned 75,689 shares of the company's stock, valued at $8,519,553.84. The trade was a 43.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jon Kessler sold 97,767 shares of the business's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.05, for a total value of $10,954,792.35. Following the sale, the director directly owned 75,000 shares in the company, valued at $8,403,750. The trade was a 56.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 291,744 shares of company stock valued at $32,705,007 over the last ninety days. 1.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

HQY has been the topic of several analyst reports. The Goldman Sachs Group lifted their target price on HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research report on Wednesday, June 4th. JMP Securities boosted their price objective on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. Royal Bank Of Canada boosted their price objective on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research report on Wednesday, June 4th. Raymond James Financial restated a "strong-buy" rating and issued a $120.00 price objective (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, June 5th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $118.55.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.